Edited by: Shigehiko Ogoh
Introduction
The molecular and cellular changes in heat stress are integrative and complex. Initially, heat stress incites an acute phase cytokine response that protects and repairs tissues but can progress into a pro-inflammatory and procoagulative state when severe (Bouchama & Knochel, 2002) . Tissue injury in heat stroke (clinically defined as a core temperature above 40°C with the presence of central nervous system dysregulation) consequently arises not only from the direct cytotoxic effect of heat but also from progressive inflammatory and hypercoagulant responses of the host (Bouchama & Knochel, 2002; Leon & Bouchama, 2015) . The cellular changes associated with progressive heat stress might involve a contribution from circulating microparticles.
Microparticles are small (100-1000 nm) membrane vesicles that are released into the circulation by various cell types (e.g. endothelial cells, platelets, leucocytes and monocytes) in response to a myriad of physiological and pathological processes, indicative of cellular activation or apoptosis. Clinical interest in circulating microparticles, particularly those derived from endothelial cells (EMPs) and platelets (PMPs), has increased because of their potential pathogenic role in vascular disease and procoagulant states (Stępień et al. 2012; Barteneva et al. 2013) , and as biomarkers of vascular health (Horstman et al. 2004; Martínez et al. 2005) . Important to the cellular process of progressive heat stress, elevations in circulating microparticles and coagulation markers have been reported in a baboon model of heat stroke (Gilbert et al. 1991) . It is currently unknown, however, whether circulating microparticles increase in response to physiological levels of heat stress, i.e. core temperature no greater than 40°C, in healthy adult humans.
Accordingly, the experimental aim of this study was to determine the effects of passive heat stress on circulating arterial concentrations of EMPs and PMPs in healthy adults. Owing to the known hypercoagulant state associated with severe pathological hyperthermia, it was hypothesized that passive heat stress of +2°C core temperature would cause an increase in circulating EMPs and PMPs. Whole-body heating to induce a +2°C rise in core body (oesophageal) temperature was achieved using a warm-water-perfused suit. Circulating concentrations of EMPs and PMPs were determined from arterial blood samples taken in normothermia (before heating) and in hyperthermia.
Methods
Ethical approval. All experimentation was completed at the Centre for Heart, Lung & Vascular Health, University of British Columbia, Kelowna, BC, Canada. The ethical committee of the University of British Columbia approved the study (H15-00166). The study conformed to the standards set by the Declaration of Helsinki. All subjects provided informed written consent before experimentation.
Subjects. Ten healthy young men (age 23 ± 3 years) were studied. All subjects were non-obese (body mass index 23.0 ± 2.0 kg m −2 ), normotensive (blood pressure 118/70 ± 6/7 mmHg), normoglycaemic (<99 mg dl −1 ), non-smoking and free of overt cardiometabolic and respiratory disease.
Experimental protocol. Subjects arrived at the laboratory after a minimum 4 h fast and 12 h abstinence from alcohol-and caffeine-containing beverages. Under local anaesthesia (1% lidocaine) and ultrasound guidance, a 20-gauge arterial catheter (Arrow, Markham, ON, Canada) was placed in the right radial artery. For measures of arterial blood pressure, the radial catheter was attached to a pressure transducer positioned at the height of the right atrium (TruWave transducer; Edwards Lifesciences, Irvine, CA, USA). Heart rate was obtained from the R-R intervals measured from a three-lead ECG. Finally, a thermocouple probe (RET-1; Physitemp Instruments, Clifton, NJ, USA) was inserted 40 cm past the nostril into the oesophagus for measures of core temperature.
After arterial cannulation and insertion of the oesophageal thermometer, subjects were fitted into a tube-lined suit (Med-Eng, Ottawa, ON, Canada) that covered the entire body except the head, feet and hands. After 15 min of supine rest, a baseline blood sample was collected from the radial artery. Thereafter, the tube-lined suite was perfused with 49°C water until the subjects reached an oesophageal temperature of +2°C above baseline, an absolute core temperature of 39.5°C or at the subject's volitional thermal tolerance, at which point a second blood sample was collected. Circulating microparticles in heat stress Microparticle isolation and identification. Microparticle isolation and identification was based on accepted methodology, as described by Jenkins et al. (2013) and Durrer et al. (2015) . Briefly, arterial blood was collected into tubes containing sodium citrate and centrifuged at 1500g for 10 min at room temperature; thereafter, platelet-poor plasma was collected and stored at −80°C for batch analysis. For the characterization and quantification of circulating microparticle subspecies, platelet-poor plasma was thawed and centrifuged at 13,000g for 2 min, yielding platelet-free plasma, and 100 μl was transferred to a TruCount tube (BD Biosciences, Franklin Lakes, NJ, USA). The EMP phenotype was determined using markers indicative of endothelial activation (CD62E) and apoptosis (CD31/CD42b; BioLegend, San Diego, CA, USA). The PMP phenotype was determined by using markers indicative of platelet activation (CD62P). Samples were incubated with the flourochrome-labelled antibodies for 20 min in a dark at room temperature. After incubation, samples were fixed with 2% paraformaldehyde (ChemCruz Biochemicals, Santa Cruz, CA, USA) and diluted with RNAse-free PBS. The microparticle size threshold was established using Megamix-Plus SSC calibrator beads (Biocytex, Marseille, France), and only events <1 μm in size and positively expressing markers of endothelial activation (CD62E + ), apoptosis (CD31 + /CD42b − ) and platelet activation (CD62P) were counted. Samples were analysed using BD Biosciences FACSAria I High Speed Cell sorter and flow cytometer (University of Colorado Anschutz Medical Campus Allergy and Clinical Immunology/Infectious Disease Flow Core). Importantly, the flow cytometry used has a forward-and side-scatter sensitivity that has been clinically validated for identification of 0.5 μm beads. The use of MegaMix Plus-SSC fluorescent beads, with various diameters (0.16, 0.20, 0.24 and 0.5 μm) , ensures the FACSAria is capable of analysing microparticles at its inferior limits. The concentrations of EMPs and PMPs were determined using the following formula: [(number of events in region containing microparticles/number of events in absolute count bead region) × (total number of beads per test/total volume of sample)] (Nielsen et al. 2014) .
Statistical analysis. All data are denoted as means ± SD. After testing the data for normality with repeated Shapiro-Wilk W tests, differences from baseline to heat stress were assessed using two-tailed Student's paired t tests. Significance was determined at an α of P < 0.05.
Results
The passive heating protocol resulted in an increase in the oesophageal temperature from 37.2 ± 0.2 to 39.1 ± 0.4°C. The total heating time (i.e. time elapsed from baseline to heat stress) was 56 ± 4 min. Only three of the subjects requested termination of the heating before reaching an oesophageal temperature of +2°C. Whole-body heating resulted in a significant increase in heart rate (from 65 ± 10 to 120 ± 14 beats min −1 ) and a reduction in mean arterial blood pressure (from 91 ± 7 to 78 ± 10 mmHg).
Circulating arterial concentrations of EMPs and PMPs were markedly affected by passive heat stress. Changes in activation-and apoptosis-derived EMPs are shown in Fig. 1 . Heat stress resulted in a ß30% reduction in activation-derived EMPs (from 61 ± 26 to 43 ± 21 microparticles μl −1 ; P < 0.05) and a ß45% reduction in apoptosis-derived EMPs (from 46 ± 23 to 23 ± 9 microparticles μl −1 ; P < 0.05). In addition, circulating PMPs were significantly reduced (ß75%) in response to heat stress (from 256 ± 135 to 62 ± 46 microparticles μl −1 ; Fig. 2 ). 
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Discussion
The new finding of the present study is that passive heat stress (2°C increase in oesophageal temperature) reduces circulating arterial concentrations of EMPs and PMPs in young healthy men. To our knowledge, this is the first study to determine the effects of passive heat stress on circulating microparticles. These surprising findings potentially represent novel favourable effects that buttress the vascular benefits previously reported with non-pathophysiological hyperthermia (Umscheif et al. 2010; Ohori et al. 2012; Laukkanen et al. 2015; Brunt et al. 2016; Romero et al. 2017) . The notion of therapeutic benefits from controlled hyperthermia is not new (Lee Titsworth et al. 2014 ) but has recently gained interest in large part after a 30 year prospective study (Laukkanen et al. 2015) indicating that lifetime sauna use is associated with lower rates of cardiovascular system-related deaths. In addition, Brunt et al. (2016) recently reported that 8 weeks of passive whole-body heat therapy (hot water immersion until a rectal temperature of 38.5°C, four or five times per week) reduced resting systolic and diastolic blood pressure, arterial stiffness and carotid intima-media thickness and improved flow-mediated dilatation of the brachial artery in young adults. Remarkably, these vascular changes were comparable to improvements generally associated with aerobic exercise training (Wilson et al. 2016) . Moreover, the improvements in vascular function were observed as early as 2 weeks into the heat intervention, suggesting rapid endothelial adaptation to this stimulus. An acute vascular improvement (increased macro-and microvascular dilator function) with a single heat stress bout has also been shown in older men (Romero et al. 2017) . The results presented herein complement and significantly extend these findings by demonstrating that acute passive heat stress induces marked reductions in circulating arterial EMPs (ß35%) and PMPs (ß75%). Elevated EMPs and PMPs are established biomarkers of endothelial damage (Horstman et al. 2004; Viera et al. 2012; Melki et al. 2017) , arterial stiffness (Chen et al. 2012) and systemic vascular dysfunction (Amabile et al. 2005) . Reductions in circulating EMPs and PMPs may be a consequence, and an indicator, of favourable endothelial and platelet responses to physiological heat stress. Endothelial cells release phenotypically and quantitatively distinct microparticles dependent upon cell activation or apoptosis (Jimenez et al. 2003) , and both forms provide insight regarding the status of the endothelium, serving as early physiological signals of vascular distress (Yong et al. 2013) . Indeed, both activation-and apoptosis-derived EMPs are thought to be causative agents in vascular pathology, contributing to vascular dysfunction, inflammatory processes and, ultimately, atherogenesis. For example, EMPs have been implicated in promoting endothelial oxidative stress (Burger et al. 2011) , diminishing nitric oxide bioavailability (Jimenez et al. 2003) , enhancing cell adhesion molecule expression (Burger et al. 2011) and impairing endothelial vasomotor function (Brodsky et al. 2004) . In the present study, passive heat stress reduced circulating arterial concentrations of both activation-and apoptosis-derived EMPs in healthy young men, potentially reflecting an advantageous endothelial response to the heating stimulus.
Platelet-derived microparticles also adversely affect endothelial function and contribute to a pro-atherogenic environment by promoting inflammation and thrombosis (Melki et al. 2017) . Released as a result of platelet activation, PMPs can, in turn, induce endothelial cell activation and apoptosis and trigger various coagulation pathways. For example, PMPs have been shown to stimulate endothelial cells to release inflammatory cytokines, such as interleukin-6 and interleukin-8, and express various pro-atherogenic adhesion molecules, such as intracellular adhesion molecule-1, vascular cell adhesion-1 and E-selectin (Barry et al. 1998; Nomura et al. 2001; Mause et al. 2005) .
A reduction in PMPs with heat stress suggests a reduction in platelet activation, a finding consistent with in vitro studies (Pasha et al. 1995; Etulain et al. 2011) . For example, Etulain et al. (2011) reported that platelet adhesion, aggregation and ATP release were diminished when exposed to a higher-temperature (38.5-42°C) microenvironment. Mechanistically, reduced platelet activation with heat exposure is attributed to decreased p38 signalling (Etulain et al. 2011) . Given that p38 mitogen-activated protein kinase also causes a release of pro-inflammatory EMPs (Curtis et al. 2009) , it stands to reason that reduced p38 activity with heat stress might contribute to the reduction in both PMPs and EMPs reported in the present study. In fact, heat stress (Liu et al. 2016b ) and heat stress pretreatment (Liu et al. 2016a ) inhibit lipolysaccharide-induced apoptosis via inhibition of the p38 signalling pathway. Decreased EMPs in passive heat stress might also result from changes in blood flow shear patterns; that is, passive heat stress increases anterograde and decreases retrograde shear rate (Romero et al. 2017) . Given that an acute reduction in anterograde and increase in retrograde shear is associated with marked increases in EMPs (Jenkins et al. 2013) , it is conceivable that vice versa is true, i.e. increased anterograde and decreased retrograde shear could cause a reduction in EMPs.
In addition to reduced microparticle release, passive heat stress might also increase microparticle clearance. Clearance occurs predominantly by phagocytosis, endocytosis, micropinocytosis and membrane fusion (Ayers et al. 2015) . The cells and organs involved include the epithelial cells, endothelial cells and macrophages and the lungs, spleen and liver, respectively (Ayers et al. 2015) . A heat-induced increase in microparticle clearance in the liver and spleen is unlikely given the known hyperthermia-induced reductions in splanchnic blood flow (Deschamps & Magder, 1994) . However, candidate mechanisms favouring heat-induced microparticle clearance include macrophage phagocytosis and uptake by endothelial cells. For example, microparticle clearance via macrophages might be increased in heat stress from augmented T-cell activity (Ostberg et al. 2001) . Meanwhile, microparticle uptake at endothelial cells might be increased via proliferation of the developmentally regulated endothelial cell locus 1 (DEL-1) from upregulated vascular endothelial growth factor signalling (Kanamori et al. 1999; Aoki et al. 2005) .
It is important to emphasize that the degree of acute heat stress used in the present study represents a physiological (non-pathological) challenge exclusive to healthy young men; as such, the results of our study should be viewed within this context. More severe levels of hyperthermia (core temperature exceeding 40°C) might result in elevated concentrations of circulating EMPs and PMPs. Indeed, lipid membranes are vulnerable to high temperatures (Balogh et al. 2013) , as excessive heat can increase the flux of extracellular Ca 2+ into the cytosol via cyclic nucleotide-gated Ca 2+ channels (Finka et al. 2012; Balogh et al. 2013 ). An increased transmembrane cation flux disrupts the enzymatic activity of the lipid transporters aminophospholipid translocase (flippase), floppase and scramblase and activates cytoskeletal proteases (e.g. calpains). This, in turn, can destabilize the cell membrane and cause microparticle release (Roseblade et al. 2013) . Future studies are needed to determine circulating microparticle concentrations with varying degrees of hyperthermia. Given the adverse vascular and haemostatic consequences of heat stroke, microparticles might be important aetiologically.
Moreover, it is entirely unknown whether microparticle concentrations are reduced with smaller core temperature elevations generally attained in therapeutic hyperthermia (i.e. +1-1.5°C core temperature). The time course of reduced microparticle concentrations following a return to normothermia and with long-term (weeks) bouts of repeated hyperthermia (heat acclimation) also remains unknown. Lastly, a limitation of the present study is the lack of any functional vascular measure, which should be assessed in future study.
In conclusion, the results of the present study indicate that acute passive heat stress of +2°C core temperature lowers circulating arterial concentrations of EMPs and PMPs in young healthy adult men. Reductions in circulating EMPs and PMPs may contribute to the vascular benefits associated with whole-body heat therapy. These results are exclusive to healthy young men, and future studies are needed to determine whether they extend to women, middle-aged and older adults, as well as to disease populations.
